Parkinson's Disease and Its Management: Part 3: Nondopaminergic and Nonpharmacological Treatment Options.
Year: 2015
Type: article
Abstract: This installment of a five-part series reviews the role of nondopaminergic pharmacotherapies and adjunctive options-such as monoamine oxidase type B inhibitors, catechol-O-methyltransferase inhibitors, and anticholinergic agents-in managing Parkinson's disease. Nonpharmacological treatments are also explored.
Source: Europe PMC (PubMed Central)
Authors: George DeMaagd, Ashok Philip
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2127366278
